Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency

NCT07140679 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT07140679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07140679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Adjuvant Toripalimab in High Risk Localized Colon Cancer With Mismatch Repair Deficiency
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Recruiting
Start date
September 19, 2025
Completion date
December 31, 2031
Enrollment
40 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

localized colon carcinoma, stage iib colon cancer ajcc v8, stage iic colon cancer ajcc v8, stage iii colon cancer ajcc v8